Cargando…

Current Status of Internal Cardioversion in Atrial Fibrillation

Detalles Bibliográficos
Autores principales:	Plewan, Andreas, Alt, Eckhard
Formato:	Texto
Lenguaje:	English
Publicado:	Indian Pacing and Electrophysiology Group 2002
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564052/ https://www.ncbi.nlm.nih.gov/pubmed/17006555

Ejemplares similares

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
por: Demirel, Ozan, et al.
Publicado: (2023)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
por: Walsh, Simon J, et al.
Publicado: (2005)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Adjunctive Pharmacotherapy for Elective Direct Current Cardioversion in Patients With Atrial Fibrillation
por: Hirt, Liam S., et al.
Publicado: (2012)

Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation
por: Meyre, Pascal B., et al.
Publicado: (2022)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence
por: Sawasaki, Kohei, et al.
Publicado: (2021)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
por: Mariani, Marco Valerio, et al.
Publicado: (2022)

Comparison of clinical outcomes of Ibutilide-guided cardioversion and direct current synchronized cardioversion after radiofrequency ablation of persistent atrial fibrillation
por: Liu, Xing, et al.
Publicado: (2023)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

Comparison of monophasic versus biphasic cardioversion for atrial fibrillation
por: Vaisman, M, et al.
Publicado: (2005)

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation
por: Alkhatib, Deya, et al.
Publicado: (2022)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

The Impact of Right Atrial Size to Predict Success of Direct Current Cardioversion in Patients With Persistent Atrial Fibrillation
por: Döring, Christoph, et al.
Publicado: (2023)

Feasibility and safety of the direct current cardioversion at the time of left atrial appendage occlusion for patients with atrial fibrillation
por: Meng, Xian Sai, et al.
Publicado: (2023)

Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation
por: Lobo, Ronstan, et al.
Publicado: (2022)

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers
por: Crijns, Harry JGM, et al.
Publicado: (2012)

Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Prasai, Paritosh, et al.
Publicado: (2023)

Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2010)

Sternal fracture after elective electrical cardioversion of atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2010)

Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation
por: Rochlani, Yogita M., et al.
Publicado: (2016)

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
por: Jacobs, Maartje S., et al.
Publicado: (2017)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
por: Höglund, Niklas, et al.
Publicado: (2017)

Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ucehkvpl7o1t6jeilapp0rl0h0